日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study

在 t(11;14) 阳性复发/难治性多发性骨髓瘤中,维奈托克-地塞米松与泊马度胺-地塞米松的疗效比较:随机 III 期 CANOVA 研究的主要结果

Popat, Rakesh; Beksac, Meral; Dimopoulos, Meletios A; Gatt, Moshe E; Gay, Francesca; Jo, Jae-Cheol; Kapoor, Prashant; Katodritou, Eirini; Kortüm, K Martin; Ling, Silvia; Nagarajan, Chandramouli; Suzuki, Kenshi; Qiu, Lugui; Onishi, Maika; Ku, Grace; Dail, Monique; Mukherjee, Nabanita; Ross, Jeremy A; Badawi, Mohamed Ali; Fusco, Mary Jean; Dobkowska, Edyta; Arriola, Emma; Bueno, Orlando F; Bahlis, Nizar J; Iida, Shinsuke; Moreau, Philippe; Valent, Jason; Mateos, María-Victoria

Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs

与使用抗GPRC5D双特异性抗体治疗的多发性骨髓瘤患者相比,使用抗BCMA抗体治疗的多发性骨髓瘤患者感染风险增加的根本原因在于选择性B细胞亚群耗竭。

Jelinek, Tomas; Zihala, David; Zabaleta, Aintzane; Kostopoulos, Ioannis V; Soucek, Ondrej; Venglar, Ondrej; Moreno, Cristina; Fotiou, Despina; Radova, Eva; Tamariz-Amador, Luis Esteban; Theodorakakou, Foteini; Muronova, Ludmila; Manubens, Andrea; Tsitsilonis, Ourania; Popkova, Tereza; Gonzalez, Carmen; Anilkumar Sithara, Anjana; Corrado, Francesco; Bidikian, Nayda; Guerrero, Camila; Kapustova, Veronika; Bilek, Daniel; Hagner, Patrick R; Larrayoz, Marta; Martinez Climent, Jose A; Broskevicova, Lucie; Mihalyova, Jana; Merz, Maximilian; Sevcikova, Tereza; Ghobrial, Irene M; San Miguel, Jesus; Dimopoulos, Meletios A; Rodriguez-Otero, Paula; Radocha, Jakub; Kastritis, Efstathios; Paiva, Bruno; Hajek, Roman

Belantamab mafodotin, lenalidomide, and dexamethasone for intermediate-fit and frail patients with newly diagnosed myeloma

贝兰他单抗、来那度胺和地塞米松用于治疗中等体能和体弱的新诊断多发性骨髓瘤患者

Terpos, Evangelos; Gavriatopoulou, Maria; Ntanasis-Stathopoulos, Ioannis; Malandrakis, Panagiotis; Fotiou, Despina; Kanellias, Nikolaos; Migkou, Magdalini; Theodorakakou, Foteini; Spiliopoulou, Vasiliki; Solia, Eirini; Eleutherakis-Papaiakovou, Evangelos; Psarros, Giorgos; Kastritis, Efstathios; Dimopoulos, Meletios A

Pharmacological inhibition of sclerostin protects bone from B‐cell acute lymphoblastic leukemia‐mediated destruction

药物抑制硬骨蛋白可保护骨骼免受B细胞急性淋巴细胞白血病介导的破坏。

Anargyrou, Konstantinos; Fotiou, Despina; Vassilakopoulos, Theodoros P; Christoulas, Dimitrios; Makras, Polyzois; Dimou, Maria; Ntanasis-Stathopoulos, Ioannis; Masouridou, Stavroula; Angelopoulou, Maria K; Papatheodorou, Athanasios; Tsionos, Konstantinos; Panayiotidis, Panayiotis; Dimopoulos, Meletios A; Terpos, Evangelos; Kuek, Vincent; Oommen, Joyce; Ferrari, Emanuela; Yuan, Jinbo; Economides, Aris N; Lock, Richard B; Malinge, Sebastien; Kotecha, Rishi S; Cheung, Laurence C

POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia

POD24 是华氏巨球蛋白血症患者预后的一个新的决定因素

Zanwar, Saurabh; Abeykoon, Jithma; D'Sa, Shirley; Roos-Weil, Damien; Larson, Dirk R; Colby, Colin L; Durot, Eric; Kastritis, Efstathios; Uppal, Encarl; Tomkins, Oliver; Morel, Pierre; Mondello, Patrizia; Montes, Lydia; Paludo, Jonas; Ailawadhi, Sikander; Sarosiek, Shayna; Ogunbiyi, Olabisi; Cornillet-Lefebvre, Pascale; Rajkumar, S Vincent; Quinquenel, Anne; Dispenzieri, Angela; Fonseca, Rafael; Gertz, Morie A; Kumar, Shaji; Dimopoulos, Meletios A; Ansell, Stephen M; Treon, Steven; Castillo, Jorge J; Kapoor, Prashant

A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma

一项针对复发/难治性多发性骨髓瘤患者的莫达卡福斯普α单药治疗的II期随机研究

Holstein, Sarah A; Atrash, Shebli; Mian, Hira; Dimopoulos, Meletios A; Schjesvold, Fredrik; Popat, Rakesh; Shah, Nishi; Gatt, Moshe E; Gocke, Christian B; Frenzel, Laurent; Touzeau, Cyrille; Beksac, Meral; Manier, Salomon; Magen, Hila; Travis, Patrick; Nadeem, Omar; Suryanarayan, Kaveri; Li, Cheryl; Li, Shuli; Nelson, Allison; Cherepanov, Dasha; Parot, Xavier; Vogl, Dan T

Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's Macroglobulinemia.

单细胞 RNA 测序定义了不同的疾病亚型,并揭示了无症状华氏巨球蛋白血症对干扰素的低反应性

Sklavenitis-Pistofidis Romanos, Konishi Yoshinobu, Heilpern-Mallory Daniel, Wu Ting, Tsakmaklis Nicholas, Aranha Michelle P, Hunter Zachary R, Ali Alaa K, Tsuji Junko, Haradhvala Nicholas J, Lightbody Elizabeth D, Towle Katherine, Hevenor Laura, Romee Rizwan, Briercheck Edward L, Smith Eric L, Liacos Christine-Ivy, Kastritis Efstathios, Dimopoulos Meletios A, Treon Steven P, Getz Gad, Ghobrial Irene M

Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network

多发性骨髓瘤患者静脉血栓栓塞的预防和治疗:欧洲骨髓瘤网络临床实践指南

Gerotziafas, Grigoris; Fotiou, Despina; Nijhof, Inger; Ay, Cihan; Lecumberri, Ramon; Laroca, Alessandra; Cook, Gordon; Engelhardt, Monika; Zweegman, Sonja; Delforge, Michel; Maraveyas, Anthony; Lefkou, Eleftheria; Marchetti, Marina; Van de Donk, Niels W C J; Gay, Francesca; Ludwig, Heinz; Einsele, Hermann; San Miguel, Jesus F; Dimopoulos, Meletios A; Boccadoro, Mario; Sonneveld, Pieter; Falanga, Anna; Terpos, Evangelos

Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network

多发性骨髓瘤中BCMA和GPRC5D靶向免疫疗法的测序:来自欧洲骨髓瘤网络的实用指南

van de Donk, Niels W C J; Moreau, Philippe; San-Miguel, Jesus F; Mateos, Maria-Victoria; Dimopoulos, Meletios A; Zweegman, Sonja; Gay, Francesca; Engelhardt, Monika; Mina, Roberto; Zamagni, Elena; Delforge, Michel; Beksac, Meral; Spencer, Andrew; Schjesvold, Fredrik; Driessen, Christoph; Kaiser, Martin; Perrot, Aurore; Wäsch, Ralph; Korst, Charlotte L B M; Broijl, Annemiek; Touzeau, Cyrille; Manier, Salomon; Hajek, Roman; Bila, Jelena; Seval, Guldane C; O'Dwyer, Michael; Ludwig, Heinz; Fernandez de Larrea, Carlos; Popat, Rakesh; Musto, Pellegrino; Rodriguez-Otero, Paula; Yong, Kwee; Kortüm, Marin; Rasche, Leo; Terpos, Evangelos; Raab, Marc S; Boccadoro, Mario; Sonneveld, Pieter; Einsele, Hermann

Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study

真实世界评估teclistamab治疗复发/难治性多发性骨髓瘤(RRMM)的疗效:国际骨髓瘤工作组研究

Tan, Carlyn Rose; Asoori, Sireesha; Huang, Chiung-Yu; Brunaldi, Larissa; Popat, Rakesh; Kastritis, Efstathios; Martinez-Lopez, Joaquin; Bansal, Radhika; Silva Corraes, Andre De Menezes; Chhabra, Saurabh; Parrondo, Ricardo; Ailawadhi, Sikander; Fotiou, Despina; Dimopoulos, Meletios A; Yong, Kwee; Mactier, Catriona; Lau, Chris; Corona, Magdalena; Marin, Adolfo Jesús Sáez; Mian, Hira; Durie, Brian Gm; Usmani, Saad Z; Martin, Thomas G; Lin, Yi